ArticleThe Journal of clinical investigation1991

Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.

H R Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.